• Explore /
  • Poster
  • / Radiotherapy alone vs radiotherapy with concurrent chemoradiotherapy in patients with low-risk nasopharyngeal carcinoma: Updated results from a multicenter, open-label, non-inferiority, randomized phase III trial.

Radiotherapy alone vs radiotherapy with concurrent chemoradiotherapy in patients with low-risk nasopharyngeal carcinoma: Updated results from a multicenter, open-label, non-inferiority, randomized phase III trial.

Abstract Poster

Authors

null

Rui Guo

Department of Radiation Oncology, Sun Yat-sen University Cancer Center; Collaborative Innovation Center for Cancer Medicine; State Key Laboratory of Oncology in South China; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China

Rui Guo , Yuan Zhang , Ning Zhang , Bin Deng , Zhi-Bin Cheng , Jing Huang , Fan Zhang , Yan-Ping Mao , Wen-Fei Li , Guan-Qun Zhou , Yu-Pei Chen , Cheng Xu , Li Lin , Wei-Wei Zhang , Xu Jiang , Qing Liu , Ying Sun , Jun Ma , Lei Chen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session B

Track

Thoracic Cancers,Breast Cancer,Gynecologic Cancer,Head and Neck Cancer,Hematologic Malignancies,Genetics/Genomics/Multiomics,Healthtech Innovations,Models of Care and Care Delivery,Viral-Mediated Malignancies,Other Malignancies or Topics

Sub Track

Local Disease

Clinical Trial Registration Number

NCT02633202

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr 142)

DOI

10.1200/JCO.2024.42.23_suppl.142

Abstract #

142

Poster Bd #

E7

Abstract Disclosures

Similar Posters

First Author: Min Kang

First Author: Cheng Xu

First Author: Min Kang

First Author: Kuiyuan Liu